Project Grant R15HL184249
Award Date 7/25/26
Completion Date 6/30/29
Dollars Obligated $580K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Arlington, TX 76019, USA
Similar Awards
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Texas at Arlington $378,411 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop super-resolution tomographic imaging technology for deep tissue visualization. The project aims to overcome diffraction limits inherent in existing super-resolution imaging modalities—including super-resolution fluorescence...
- The National Heart, Lung, and Blood Institute awarded the University of Texas at Arlington $113,788 on August 14, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate how changes in shared public activity spaces—such as walking trails, parks, and sidewalks—affect long-term hypertension risk trajectories in aging adults. The research uses longitudinal data from the nationally representative Health and Retirement Study to identify physical activity-related pathways...
- The National Heart, Lung, and Blood Institute awarded The University of Texas Southwestern Medical Center $143,461 on April 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct high-resolution phenotyping of hemodynamic consequences in adults who have undergone thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysm. The research assesses how graft material stiffness following TEVAR affects pressure, wave reflections, and pulsatility in...
- The National Heart, Lung, and Blood Institute awarded the University of Texas Health Science Center at Houston $328,278 on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate artificial intelligence-based screening tools for heritable thoracic aortic disease and identify novel genetic drivers of the condition. The award funds development of an AI-powered facial recognition tool designed to identify individuals at risk for thoracic aortic...
- The National Heart, Lung, and Blood Institute awarded the University of Virginia $760,465 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop deep learning methods that advance cardiac magnetic resonance strain imaging for personalized cardiac resynchronization therapy treatment planning. The award funds development of deep strain networks to rapidly and accurately predict myocardial displacements from cardiac magnetic resonance imaging, addressing...
- The National Heart, Lung, and Blood Institute awarded the University of Texas at Austin $238,858 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop personalized prediction models for HER2-induced cardiovascular adverse events in older women with breast cancer using artificial intelligence and machine learning. The award funds a cohort study using 2011–2022 Surveillance, Epidemiology, and End Results (SEER)–Medicare data linked with American...
- The National Heart Lung and Blood Institute awarded The University of Texas Southwestern Medical Center $1.371 million on September 15, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a multi-center observational study of the association between ventilation and cardiac arrest outcome. The study measures ventilation during cardiopulmonary resuscitation using thoracic bioimpedance (electrical resistance) monitored through defibrillator pads. The recipient has...
- The National Heart, Lung, and Blood Institute awarded Vanderbilt University Medical Center $174,621 on August 17, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop cardiac magnetic resonance imaging (CMR) techniques for monitoring congenital heart disease using ultra-low field (ULF) MRI systems. The recipient will adapt CMR to an inexpensive, unshielded, open-geometry ULF MRI system and apply machine learning techniques to mitigate hardware limitations and...
- The National Institutes of Health National Heart Lung and Blood Institute awarded the University of Texas at Austin $428,327 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop patient-specific, pre-procedural planning simulation tools for tricuspid valve repair. The project addresses tricuspid valve regurgitation, a condition affecting more than 1.6 million Americans, which is repaired in fewer than 10,000 patients annually due to low success...
- Federal Project Grant Summary The University of Texas Rio Grande Valley received a $222,000 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025, through July 31, 2027. The grant funds research focused on analyzing 24-hour (24-H) blood pressure dysregulations using population-based and clinical cohort data to develop innovative metrics and methodologies for understanding blood...